A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus (iNPH).

A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus (iNPH).

Introduction. Idiopathic normal pressure hydrocephalus iNPH can be misdiagnosed with other neurodegenerative diseases, especially in the early disease stages. Considering the opportunity of the shunt surgery, iNPH should be diagnosed with accuracy. Here we evaluate the utility of CSF biomarkers and...

Full description

Bibliographic Details
Main Authors:	Tommaso eSchirinzi, Giulia Maria eSancesario, Cristiano eIalongo, Paola eImbriani, Graziella eMadeo, Sofia eToniolo, Alessandro eMartorana, Antonio ePisani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-04-01
Series:	Frontiers in Neurology
Subjects:	Progressive Supranuclear Palsy CSF biomarkers Psp idiopathic normal pressure hydrocephalus iNPH
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00086/full

Similar Items

Comorbidity of diabetes mellitus in idiopathic normal pressure hydrocephalus: a systematic literature review
by: Miles Hudson, et al.
Published: (2019-02-01)

The role of perfusion and diffusion MRI in the assessment of patients affected by probable idiopathic normal pressure hydrocephalus. A cohort-prospective preliminary study
by: Francesco Tuniz, et al.
Published: (2017-09-01)

Alterations in mitochondria-endoplasmic reticulum connectivity in human brain biopsies from idiopathic normal pressure hydrocephalus patients
by: Nuno Santos Leal, et al.
Published: (2018-10-01)

Changes in cerebral glucose metabolism caused by morphologic features of prodromal idiopathic normal pressure hydrocephalus
by: Koichi Miyazaki, et al.
Published: (2019-12-01)

Effects of Robot Assisted Gait Training in Progressive Supranuclear Palsy (PSP): a preliminary report.
by: Patrizio eSale, et al.
Published: (2014-04-01)

Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
by: Piotr Alster, et al.
Published: (2020-03-01)

Centrality of striatal cholinergic transmission in basal ganglia function
by: Paola eBonsi, et al.
Published: (2011-02-01)

Functional modeling of the craniospinal system for in-vitro parameter studies on the pathogenesis of NPH
by: Benninghaus Anne, et al.
Published: (2017-09-01)

iNPH—the mystery resolving
by: Ville Leinonen, et al.
Published: (2021-03-01)

Effects of combined treatment with rosiglitazone and NPH insulin on carbohydrate metabolism in patients with type 2 diabetes mellitus
by: O A Kandalintseva, et al.
Published: (2008-12-01)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
by: Maria Angela Samis Zella, et al.
Published: (2020-07-01)

The "hummingbird" lady: A case report on progressive supranuclear palsy
by: Mosam V Phirke, et al.
Published: (2015-01-01)

Progressive supranuclear palsy: A systematic review
by: L. Rampello, et al.
Published: (2005-11-01)

Deep Brain Stimulation Surgery for Parkinson Disease Coexisting With Communicating Hydrocephalus: A Case Report
by: Carlos Guevara, et al.
Published: (2018-11-01)

Custo-utilidade da insulina glargina e insulina isófana (NPH) para o tratamento de pacientes com diabetes mellitus tipo 2 atendidos no Sistema Único de Saúde do Município de Recife
by: CARVALHO, Dayse Cabral de
Published: (2017)

Hyperparathyroidism: A rare cause of worsening of parkinsonism
by: Bhushan R Mishal, et al.
Published: (2020-01-01)

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
by: Brent Bluett, et al.
Published: (2021-07-01)

Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment
by: Carina Kirstine Klarskov, et al.
Published: (2020-06-01)

Evaluation of immunogenicity, efficacy and safety of GP40041 compared to Humulin® NPH in patients with type 2 diabetes mellitus
by: A. G. Zalevskaya, et al.
Published: (2019-08-01)

Comparative study between two recombinant human NPH insulin formulations for the treatment of type 2 diabetes mellitus
by: Nelson Rassi, et al.

Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review
by: Dippel Franz-Werner, et al.
Published: (2011-10-01)

La belle indifférence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder
by: van Meerkerk-Aanen PJ, et al.
Published: (2017-08-01)

Diagnostic accuracy of the iNPH Radscale in idiopathic normal pressure hydrocephalus.
by: Karin Kockum, et al.
Published: (2020-01-01)

Estudo comparativo entre duas insulinas humanas recombinantes NPH no tratamento do diabetes mellitus tipo 2
by: Rassi, Nelson
Published: (2015)

CHALLENGES OF HUMANIZATION IN UPA 24HOURS
by: S. D. Leite, et al.
Published: (2017-02-01)

Parallel Quality Assessment of Emergency Departments by European Foundation for Quality Management Model and Iranian National Program for Hospital Evaluation
by: Mohammad Hasan Imani Nasab, et al.
Published: (2013-06-01)

Parallel quality assessment of emergency departments by European foundation for quality management model and Iranian national program for hospital evaluation.
by: Mohammad Hasan Imani Nasab, et al.
Published: (2013-06-01)

Paradigm-shift: radiological changes in the asymptomatic iNPH-patient to be: an observational study
by: D. C. Engel, et al.
Published: (2018-02-01)

Frontotemporal dementia as a comorbidity to idiopathic normal pressure hydrocephalus (iNPH): a short review of literature and an unusual case
by: V. E. Korhonen, et al.
Published: (2017-04-01)

Of Criteria and Men—Diagnosing Atypical Parkinsonism: Towards an Algorithmic Approach
by: Liviu Cozma, et al.
Published: (2021-05-01)

Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders
by: Cheng-Hsuan Li, et al.
Published: (2021-03-01)

Novel Insight in Idiopathic Normal Pressure Hydrocephalus (iNPH) Biomarker Discovery in CSF
by: Enrica Torretta, et al.
Published: (2021-07-01)

Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
by: E. Lau, et al.
Published: (2019-07-01)

Incidental findings of typical iNPH imaging signs in asymptomatic subjects with subclinical cognitive decline
by: Doortje C. Engel, et al.
Published: (2021-08-01)

Auto-oxidation of 5,6,7 ,8-tetrahydroneopterin
by: Arai Toshiyuki, et al.
Published: (1998-02-01)

Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany
by: Raphael Scherbaum, et al.
Published: (2021-09-01)

Challenges of humanization in UPA 24hours
by: S. D. Leite, et al.
Published: (2017-02-01)

Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years
by: Bernardo Mertes, et al.
Published: (2020-04-01)

Enhanced in vitro model of the CSF dynamics
by: Anne Benninghaus, et al.
Published: (2019-04-01)

Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study
by: Potts Lisa F, et al.
Published: (2012-03-01)